The AFFIRM Investigators. A comparison of rate control and ...
amiodarone and the majority of patients started with amiodarone or sotalol) or rate control (with beta blockers, calcium channel blockers or digoxin). Patients were followed for a mean of 3.5 years. Primary analysis demonstrated a trend toward mortality benefit in the rate control group (hazard ratio 1.15 with 95% confidence interval 0.99 to 1.34). ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- rational use of beta blockers in hypertension
- should beta blockers still be used as initial
- beta blockers for cardiovascular conditions one size
- beta blockers in the management of hypertension
- beta blockers for peripheral arterial disease
- which antihypertensives are more effective in reducing
- the affirm investigators a comparison of rate control and
- nebivolol versus other beta blockers in patients with
- treating hypertension in 2020 what are the goals how
- 1999 who ish hypertension guidelines highlights esh
Related searches
- comparison of type 1 and 2 diabetes
- comparison of photosynthesis and respiration
- example of a comparison paragraph
- example of a comparison essay
- comparison of tablets and ipads
- a recent survey of consumer search and brand choice yielded the following result
- comparison of management accounting and financial accounting
- comparison of ww1 and ww2
- comparison of wwi and wwii
- the joint commission big book of ec em and ls checklists
- unbiased comparison of trump and biden
- the hrning moment diagram of a multi cylinder engine is drawn with a scale of 1